Memantine
Alzheimer's medicine for moderate to severe stages.
- Starts working
- Varies
- Half-life
- 60–100 hours
- In use since
- 2003
- Pregnancy
- Use with caution
Overview
Memantine can modestly help thinking, daily function and agitation in moderate to severe Alzheimer's disease. It's often combined with donepezil and is generally well tolerated.
Conditions it's used for
How it works
Protects brain cells from too much stimulation.
Memantine belongs to the NMDA receptor antagonists. How NMDA receptor antagonists work: shield brain cells from too much glutamate signalling.
Uses
- Moderate to severe Alzheimer's disease
Available as: tablet, oral solution, capsule.
Typical dose
- Adults
- 5 mg a day, increased weekly to 20 mg a day.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Dizziness
- Headache
- Constipation
- Sleepiness
Serious — get medical help
Uncommon, but need prompt attention
- Confusion or hallucinations (rare)
- Seizures (rare)
Warnings
- Lower dose in kidney disease
Interactions
- Amantadine, ketamine, dextromethorphan — similar effects
Pregnancy and breastfeeding
Use with caution
No data.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Namenda, Namzaric (with donepezil)
- United Kingdom
- Ebixa
- India
- Admenta, Mentadem
- Australia
- Ebixa
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Can it be combined with donepezil?
Yes, they work differently and are often used together.
Do I need a prescription for Memantine?
Yes — Memantine is prescription-only in most countries.
Can I take Memantine during pregnancy?
Use with caution. No data. Always check with a doctor or midwife.
Related medicines
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — N06DX01
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.